Member Info for Aether

Doc83 - Why respond to "Andyb4"? It is obviously ill. They want your attention because nobody in the real world gives them any. Green bin the garbage.

dunk1973 - You're giving him what he wants: attention.

Green bin the dross.

Don't feed it. The person is obviously unhinged and has personality disorder or seriously mentally ill.

If we're not on a PT or JV by October, this investment becomes a very long term hold or a tax right off.

The positive thing here is the product is a broad spectrum anti-viral and is supported by major players in healthcare in the USA, e.g. Rick Bright.

The Strive trial is very important.

Not long to find out now.

If Synairgen are not on a trial by 21 Feb, what are POLY/TFG's options?

I think we need to check if the position advertised really is current.

Also, talk of an EUA is given RM's statemement on the matter unlikely.

If POLY/TFG do opt for a fire sale after 21 Feb, how much would anyone be prepared to pay for it?

I recently sent an email to Synairgen asking what their plans were given the current and likely future circumstances without a trial. I received this reply from Brooke Clarke today:

Richard provided an update by way of a LinkedIn post last week summarising progress from last year and restating the company’s focus. In case you missed it, you can find it [here].

As we have previously communicated, we believe that SNG001 could be a very valuable broad-spectrum antiviral so continue to actively pursue and refine multiple clinical approaches including company- and investigator-sponsored studies and possibly platform studies (as and when appropriate), to confirm the most expeditious clinical development path for SNG001.

As such, we continue our focus our discussions with investigators, regulatory authorities, the pharmaceutical and biotech industry, platform trial organisers, NGOs and government bodies to identify and establish the optimal method of conducting further trials to provide us with the evidence we need for a regulatory submission. We cannot provide a more detailed timeline at this stage, and we aren’t disclosing the specifics of these discussions and applications with specific trials. 

As soon as we have a concrete agreement, we will make an announcement.

Kind regards,

Brooke

"People talk about a new fund raise when the current capital runs out, but in the absence of a trial who would put more money into this?"

For the last 20 years, funding came from somewhere.

Someone mentioned recently that it was a regulatory requirement to have certain professional staff to be eligible for some trials.

Someone mentioned recently, it was a regulatory requirement to have certain professional staff to be eligible for some trials.

anujsharma2807 - What do you think will happen? Will POLY intervene directly or will there be some form of fund raise?

Again, the company has been going for a long time without a commercialised product. How did they manage this? Obviously, this will be important as September approaches.

Rick Bright stated clearly that the funding for Covid research had dried up. This is the obvious reason why Strive is late.
At this point, I would welcome a return on part of my investment. It is looking like a fund raise now.

xnviolet - it is not my pump lol! You have a good weekend too, bud.

xviolet wrong thread.

This is a Cross-Pump Thread.

PUMP!

Without further information, this is looking like a fund raise.

"RM, PM etc command some significant salaries. Would they give all that up for their 1 million shares being snapped up for say £1 or the like?"

That would be sobering if true.

Among the most powerful people in Pharma have clearly indicated Synairgen is a great product.

The funding has dried up for research generally as Rick Bright explained.

Once this is back, the sp will rise. If there is no funding this will be a tax-write off.

Rick Bright for one.

Also the head of the NIH stated we should have another trial.

A sane and healthy person wouldn't post what "professional" is posting.

Taking time to aggrandise oneself on an obscure AIM forum with a share with tiny volume and a huge disparity in bid offer price?

The fact he's back after being caught out with his lies shows he's stupid as well as unhinged.

More than anything, I suspect it wants the attention people don't give it in real life.